| 前收市價 | 6.31 |
| 開市 | 6.35 |
| 買盤 | 6.40 x 3800 |
| 賣出價 | 6.43 x 3800 |
| 今日波幅 | 6.30 - 6.59 |
| 52 週波幅 | 3.16 - 10.13 |
| 成交量 | |
| 平均成交量 | 5,525,766 |
| 市值 | 1.494B |
| Beta 值 (5 年，每月) | 0.82 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.30 |
| 業績公佈日 | 2024年5月02日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 13.65 |
ZacksArdelyx (ARDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Ardelyx (ARDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
InvestorPlaceThe Millionaire’s Shortcut: 3 Stocks to Transform Your Portfolio This Month
The stock market has performed remarkably well lately. Within the last 12 months, the S&P 500, a benchmark representation of the U.S. stock market comprised of the 500 largest publicly traded companies, has increased by 26%. To put that into perspective, the average return for the S&P 500 annually since its inception is approximately 10%. Thus, it has nearly tripled the average rate of return recently due to evident positive sentiment from investors. A reduction in inflation with rate cuts on th
InvestorPlaceThe Clock is Ticking: 3 Stocks Set to Explode in the Next Quarter
Finding the next great investment is alluring, almost like a siren’s song. For this, one must possess a crystal ball to identify the stocks about to soar, elevating portfolios to unprecedented heights. Ok, let’s set aside the crystal ball. Let’s dive into three titans in their own fields with stories full of potential and promise. To begin with, there is a ground-breaking therapy for irritable bowel syndrome that derives the first one’s rapid climb. And then there’s the second one, the behemoth
